Infectious diseases. Overcoming neglect of kinetoplastid diseases
Autor*in: |
Bilbe, Graeme [verfasserIn] |
---|
Format: |
Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Übergeordnetes Werk: |
Enthalten in: Science - Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883, 348(2015), 6238, Seite 974 |
---|---|
Übergeordnetes Werk: |
volume:348 ; year:2015 ; number:6238 ; pages:974 |
Links: |
---|
Katalog-ID: |
OLC1969525932 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1969525932 | ||
003 | DE-627 | ||
005 | 20230714174343.0 | ||
007 | tu | ||
008 | 160211s2015 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20160211 |
035 | |a (DE-627)OLC1969525932 | ||
035 | |a (DE-599)GBVOLC1969525932 | ||
035 | |a (PRQ)pubmed_primary_260231240 | ||
035 | |a (KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 500 |q DNB |
084 | |a LING |2 fid | ||
100 | 1 | |a Bilbe, Graeme |e verfasserin |4 aut | |
245 | 1 | 0 | |a Infectious diseases. Overcoming neglect of kinetoplastid diseases |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
650 | 4 | |a Trypanosomiasis, African - transmission | |
650 | 4 | |a Trypanosoma cruzi - drug effects | |
650 | 4 | |a Chagas Disease - transmission | |
650 | 4 | |a Kinetoplastida - drug effects | |
650 | 4 | |a Euglenozoa Infections - drug therapy | |
650 | 4 | |a Antiprotozoal Agents - adverse effects | |
650 | 4 | |a Antiprotozoal Agents - therapeutic use | |
650 | 4 | |a Euglenozoa Infections - transmission | |
650 | 4 | |a Leishmaniasis - drug therapy | |
650 | 4 | |a Antiprotozoal Agents - chemistry | |
650 | 4 | |a Chagas Disease - drug therapy | |
650 | 4 | |a Leishmaniasis - transmission | |
650 | 4 | |a Neglected Diseases - drug therapy | |
650 | 4 | |a Trypanosomiasis, African - drug therapy | |
773 | 0 | 8 | |i Enthalten in |t Science |d Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883 |g 348(2015), 6238, Seite 974 |w (DE-627)12931482X |w (DE-600)128410-1 |w (DE-576)014533189 |x 0036-8075 |7 nnns |
773 | 1 | 8 | |g volume:348 |g year:2015 |g number:6238 |g pages:974 |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26023124 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-LING | ||
912 | |a SSG-OLC-PHY | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-MAT | ||
912 | |a SSG-OLC-FOR | ||
912 | |a SSG-OLC-SPO | ||
912 | |a SSG-OLC-IBL | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-FOR | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_21 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_30 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_47 | ||
912 | |a GBV_ILN_55 | ||
912 | |a GBV_ILN_59 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_92 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_131 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_171 | ||
912 | |a GBV_ILN_179 | ||
912 | |a GBV_ILN_181 | ||
912 | |a GBV_ILN_211 | ||
912 | |a GBV_ILN_252 | ||
912 | |a GBV_ILN_259 | ||
912 | |a GBV_ILN_290 | ||
912 | |a GBV_ILN_600 | ||
912 | |a GBV_ILN_601 | ||
912 | |a GBV_ILN_647 | ||
912 | |a GBV_ILN_754 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2012 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2026 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2116 | ||
912 | |a GBV_ILN_2120 | ||
912 | |a GBV_ILN_2121 | ||
912 | |a GBV_ILN_2173 | ||
912 | |a GBV_ILN_2185 | ||
912 | |a GBV_ILN_2219 | ||
912 | |a GBV_ILN_2221 | ||
912 | |a GBV_ILN_2279 | ||
912 | |a GBV_ILN_2286 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4036 | ||
912 | |a GBV_ILN_4046 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4251 | ||
912 | |a GBV_ILN_4277 | ||
912 | |a GBV_ILN_4302 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4310 | ||
912 | |a GBV_ILN_4314 | ||
912 | |a GBV_ILN_4317 | ||
912 | |a GBV_ILN_4318 | ||
912 | |a GBV_ILN_4320 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4328 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 348 |j 2015 |e 6238 |h 974 |
author_variant |
g b gb |
---|---|
matchkey_str |
article:00368075:2015----::netosiessvroigelcoknt |
hierarchy_sort_str |
2015 |
publishDate |
2015 |
allfields |
PQ20160211 (DE-627)OLC1969525932 (DE-599)GBVOLC1969525932 (PRQ)pubmed_primary_260231240 (KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid DE-627 ger DE-627 rakwb eng 500 DNB LING fid Bilbe, Graeme verfasserin aut Infectious diseases. Overcoming neglect of kinetoplastid diseases 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Trypanosomiasis, African - transmission Trypanosoma cruzi - drug effects Chagas Disease - transmission Kinetoplastida - drug effects Euglenozoa Infections - drug therapy Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Euglenozoa Infections - transmission Leishmaniasis - drug therapy Antiprotozoal Agents - chemistry Chagas Disease - drug therapy Leishmaniasis - transmission Neglected Diseases - drug therapy Trypanosomiasis, African - drug therapy Enthalten in Science Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883 348(2015), 6238, Seite 974 (DE-627)12931482X (DE-600)128410-1 (DE-576)014533189 0036-8075 nnns volume:348 year:2015 number:6238 pages:974 http://www.ncbi.nlm.nih.gov/pubmed/26023124 GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-LING SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-FOR SSG-OLC-SPO SSG-OLC-IBL SSG-OLC-PHA SSG-OLC-DE-84 SSG-OPC-FOR GBV_ILN_11 GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_47 GBV_ILN_55 GBV_ILN_59 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_92 GBV_ILN_101 GBV_ILN_110 GBV_ILN_120 GBV_ILN_131 GBV_ILN_170 GBV_ILN_171 GBV_ILN_179 GBV_ILN_181 GBV_ILN_211 GBV_ILN_252 GBV_ILN_259 GBV_ILN_290 GBV_ILN_600 GBV_ILN_601 GBV_ILN_647 GBV_ILN_754 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2012 GBV_ILN_2015 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2116 GBV_ILN_2120 GBV_ILN_2121 GBV_ILN_2173 GBV_ILN_2185 GBV_ILN_2219 GBV_ILN_2221 GBV_ILN_2279 GBV_ILN_2286 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4036 GBV_ILN_4046 GBV_ILN_4125 GBV_ILN_4219 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4302 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4310 GBV_ILN_4314 GBV_ILN_4317 GBV_ILN_4318 GBV_ILN_4320 GBV_ILN_4324 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4700 AR 348 2015 6238 974 |
spelling |
PQ20160211 (DE-627)OLC1969525932 (DE-599)GBVOLC1969525932 (PRQ)pubmed_primary_260231240 (KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid DE-627 ger DE-627 rakwb eng 500 DNB LING fid Bilbe, Graeme verfasserin aut Infectious diseases. Overcoming neglect of kinetoplastid diseases 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Trypanosomiasis, African - transmission Trypanosoma cruzi - drug effects Chagas Disease - transmission Kinetoplastida - drug effects Euglenozoa Infections - drug therapy Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Euglenozoa Infections - transmission Leishmaniasis - drug therapy Antiprotozoal Agents - chemistry Chagas Disease - drug therapy Leishmaniasis - transmission Neglected Diseases - drug therapy Trypanosomiasis, African - drug therapy Enthalten in Science Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883 348(2015), 6238, Seite 974 (DE-627)12931482X (DE-600)128410-1 (DE-576)014533189 0036-8075 nnns volume:348 year:2015 number:6238 pages:974 http://www.ncbi.nlm.nih.gov/pubmed/26023124 GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-LING SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-FOR SSG-OLC-SPO SSG-OLC-IBL SSG-OLC-PHA SSG-OLC-DE-84 SSG-OPC-FOR GBV_ILN_11 GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_47 GBV_ILN_55 GBV_ILN_59 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_92 GBV_ILN_101 GBV_ILN_110 GBV_ILN_120 GBV_ILN_131 GBV_ILN_170 GBV_ILN_171 GBV_ILN_179 GBV_ILN_181 GBV_ILN_211 GBV_ILN_252 GBV_ILN_259 GBV_ILN_290 GBV_ILN_600 GBV_ILN_601 GBV_ILN_647 GBV_ILN_754 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2012 GBV_ILN_2015 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2116 GBV_ILN_2120 GBV_ILN_2121 GBV_ILN_2173 GBV_ILN_2185 GBV_ILN_2219 GBV_ILN_2221 GBV_ILN_2279 GBV_ILN_2286 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4036 GBV_ILN_4046 GBV_ILN_4125 GBV_ILN_4219 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4302 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4310 GBV_ILN_4314 GBV_ILN_4317 GBV_ILN_4318 GBV_ILN_4320 GBV_ILN_4324 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4700 AR 348 2015 6238 974 |
allfields_unstemmed |
PQ20160211 (DE-627)OLC1969525932 (DE-599)GBVOLC1969525932 (PRQ)pubmed_primary_260231240 (KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid DE-627 ger DE-627 rakwb eng 500 DNB LING fid Bilbe, Graeme verfasserin aut Infectious diseases. Overcoming neglect of kinetoplastid diseases 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Trypanosomiasis, African - transmission Trypanosoma cruzi - drug effects Chagas Disease - transmission Kinetoplastida - drug effects Euglenozoa Infections - drug therapy Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Euglenozoa Infections - transmission Leishmaniasis - drug therapy Antiprotozoal Agents - chemistry Chagas Disease - drug therapy Leishmaniasis - transmission Neglected Diseases - drug therapy Trypanosomiasis, African - drug therapy Enthalten in Science Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883 348(2015), 6238, Seite 974 (DE-627)12931482X (DE-600)128410-1 (DE-576)014533189 0036-8075 nnns volume:348 year:2015 number:6238 pages:974 http://www.ncbi.nlm.nih.gov/pubmed/26023124 GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-LING SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-FOR SSG-OLC-SPO SSG-OLC-IBL SSG-OLC-PHA SSG-OLC-DE-84 SSG-OPC-FOR GBV_ILN_11 GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_47 GBV_ILN_55 GBV_ILN_59 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_92 GBV_ILN_101 GBV_ILN_110 GBV_ILN_120 GBV_ILN_131 GBV_ILN_170 GBV_ILN_171 GBV_ILN_179 GBV_ILN_181 GBV_ILN_211 GBV_ILN_252 GBV_ILN_259 GBV_ILN_290 GBV_ILN_600 GBV_ILN_601 GBV_ILN_647 GBV_ILN_754 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2012 GBV_ILN_2015 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2116 GBV_ILN_2120 GBV_ILN_2121 GBV_ILN_2173 GBV_ILN_2185 GBV_ILN_2219 GBV_ILN_2221 GBV_ILN_2279 GBV_ILN_2286 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4036 GBV_ILN_4046 GBV_ILN_4125 GBV_ILN_4219 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4302 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4310 GBV_ILN_4314 GBV_ILN_4317 GBV_ILN_4318 GBV_ILN_4320 GBV_ILN_4324 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4700 AR 348 2015 6238 974 |
allfieldsGer |
PQ20160211 (DE-627)OLC1969525932 (DE-599)GBVOLC1969525932 (PRQ)pubmed_primary_260231240 (KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid DE-627 ger DE-627 rakwb eng 500 DNB LING fid Bilbe, Graeme verfasserin aut Infectious diseases. Overcoming neglect of kinetoplastid diseases 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Trypanosomiasis, African - transmission Trypanosoma cruzi - drug effects Chagas Disease - transmission Kinetoplastida - drug effects Euglenozoa Infections - drug therapy Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Euglenozoa Infections - transmission Leishmaniasis - drug therapy Antiprotozoal Agents - chemistry Chagas Disease - drug therapy Leishmaniasis - transmission Neglected Diseases - drug therapy Trypanosomiasis, African - drug therapy Enthalten in Science Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883 348(2015), 6238, Seite 974 (DE-627)12931482X (DE-600)128410-1 (DE-576)014533189 0036-8075 nnns volume:348 year:2015 number:6238 pages:974 http://www.ncbi.nlm.nih.gov/pubmed/26023124 GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-LING SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-FOR SSG-OLC-SPO SSG-OLC-IBL SSG-OLC-PHA SSG-OLC-DE-84 SSG-OPC-FOR GBV_ILN_11 GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_47 GBV_ILN_55 GBV_ILN_59 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_92 GBV_ILN_101 GBV_ILN_110 GBV_ILN_120 GBV_ILN_131 GBV_ILN_170 GBV_ILN_171 GBV_ILN_179 GBV_ILN_181 GBV_ILN_211 GBV_ILN_252 GBV_ILN_259 GBV_ILN_290 GBV_ILN_600 GBV_ILN_601 GBV_ILN_647 GBV_ILN_754 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2012 GBV_ILN_2015 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2116 GBV_ILN_2120 GBV_ILN_2121 GBV_ILN_2173 GBV_ILN_2185 GBV_ILN_2219 GBV_ILN_2221 GBV_ILN_2279 GBV_ILN_2286 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4036 GBV_ILN_4046 GBV_ILN_4125 GBV_ILN_4219 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4302 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4310 GBV_ILN_4314 GBV_ILN_4317 GBV_ILN_4318 GBV_ILN_4320 GBV_ILN_4324 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4700 AR 348 2015 6238 974 |
allfieldsSound |
PQ20160211 (DE-627)OLC1969525932 (DE-599)GBVOLC1969525932 (PRQ)pubmed_primary_260231240 (KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid DE-627 ger DE-627 rakwb eng 500 DNB LING fid Bilbe, Graeme verfasserin aut Infectious diseases. Overcoming neglect of kinetoplastid diseases 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Trypanosomiasis, African - transmission Trypanosoma cruzi - drug effects Chagas Disease - transmission Kinetoplastida - drug effects Euglenozoa Infections - drug therapy Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Euglenozoa Infections - transmission Leishmaniasis - drug therapy Antiprotozoal Agents - chemistry Chagas Disease - drug therapy Leishmaniasis - transmission Neglected Diseases - drug therapy Trypanosomiasis, African - drug therapy Enthalten in Science Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883 348(2015), 6238, Seite 974 (DE-627)12931482X (DE-600)128410-1 (DE-576)014533189 0036-8075 nnns volume:348 year:2015 number:6238 pages:974 http://www.ncbi.nlm.nih.gov/pubmed/26023124 GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-LING SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-FOR SSG-OLC-SPO SSG-OLC-IBL SSG-OLC-PHA SSG-OLC-DE-84 SSG-OPC-FOR GBV_ILN_11 GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_47 GBV_ILN_55 GBV_ILN_59 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_92 GBV_ILN_101 GBV_ILN_110 GBV_ILN_120 GBV_ILN_131 GBV_ILN_170 GBV_ILN_171 GBV_ILN_179 GBV_ILN_181 GBV_ILN_211 GBV_ILN_252 GBV_ILN_259 GBV_ILN_290 GBV_ILN_600 GBV_ILN_601 GBV_ILN_647 GBV_ILN_754 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2012 GBV_ILN_2015 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2116 GBV_ILN_2120 GBV_ILN_2121 GBV_ILN_2173 GBV_ILN_2185 GBV_ILN_2219 GBV_ILN_2221 GBV_ILN_2279 GBV_ILN_2286 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4036 GBV_ILN_4046 GBV_ILN_4125 GBV_ILN_4219 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4302 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4310 GBV_ILN_4314 GBV_ILN_4317 GBV_ILN_4318 GBV_ILN_4320 GBV_ILN_4324 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4700 AR 348 2015 6238 974 |
language |
English |
source |
Enthalten in Science 348(2015), 6238, Seite 974 volume:348 year:2015 number:6238 pages:974 |
sourceStr |
Enthalten in Science 348(2015), 6238, Seite 974 volume:348 year:2015 number:6238 pages:974 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Trypanosomiasis, African - transmission Trypanosoma cruzi - drug effects Chagas Disease - transmission Kinetoplastida - drug effects Euglenozoa Infections - drug therapy Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Euglenozoa Infections - transmission Leishmaniasis - drug therapy Antiprotozoal Agents - chemistry Chagas Disease - drug therapy Leishmaniasis - transmission Neglected Diseases - drug therapy Trypanosomiasis, African - drug therapy |
dewey-raw |
500 |
isfreeaccess_bool |
false |
container_title |
Science |
authorswithroles_txt_mv |
Bilbe, Graeme @@aut@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
12931482X |
dewey-sort |
3500 |
id |
OLC1969525932 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1969525932</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230714174343.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160211s2015 xx ||||| 00| ||eng c</controlfield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160211</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1969525932</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1969525932</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)pubmed_primary_260231240</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bilbe, Graeme</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Infectious diseases. Overcoming neglect of kinetoplastid diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trypanosomiasis, African - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trypanosoma cruzi - drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chagas Disease - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kinetoplastida - drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Euglenozoa Infections - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal Agents - adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal Agents - therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Euglenozoa Infections - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leishmaniasis - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal Agents - chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chagas Disease - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leishmaniasis - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neglected Diseases - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trypanosomiasis, African - drug therapy</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Science</subfield><subfield code="d">Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883</subfield><subfield code="g">348(2015), 6238, Seite 974</subfield><subfield code="w">(DE-627)12931482X</subfield><subfield code="w">(DE-600)128410-1</subfield><subfield code="w">(DE-576)014533189</subfield><subfield code="x">0036-8075</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:348</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:6238</subfield><subfield code="g">pages:974</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/26023124</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-MAT</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-FOR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-SPO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-IBL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_47</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_55</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_59</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_92</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_131</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_179</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_211</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_259</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_290</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_600</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_601</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_647</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_754</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2018</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2116</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2121</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2173</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2185</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2219</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2221</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2279</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2286</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4036</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4277</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4302</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4310</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4314</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4317</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4318</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4320</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4328</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">348</subfield><subfield code="j">2015</subfield><subfield code="e">6238</subfield><subfield code="h">974</subfield></datafield></record></collection>
|
author |
Bilbe, Graeme |
spellingShingle |
Bilbe, Graeme ddc 500 fid LING misc Trypanosomiasis, African - transmission misc Trypanosoma cruzi - drug effects misc Chagas Disease - transmission misc Kinetoplastida - drug effects misc Euglenozoa Infections - drug therapy misc Antiprotozoal Agents - adverse effects misc Antiprotozoal Agents - therapeutic use misc Euglenozoa Infections - transmission misc Leishmaniasis - drug therapy misc Antiprotozoal Agents - chemistry misc Chagas Disease - drug therapy misc Leishmaniasis - transmission misc Neglected Diseases - drug therapy misc Trypanosomiasis, African - drug therapy Infectious diseases. Overcoming neglect of kinetoplastid diseases |
authorStr |
Bilbe, Graeme |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)12931482X |
format |
Article |
dewey-ones |
500 - Natural sciences & mathematics |
delete_txt_mv |
keep |
author_role |
aut |
collection |
OLC |
remote_str |
false |
illustrated |
Not Illustrated |
issn |
0036-8075 |
topic_title |
500 DNB LING fid Infectious diseases. Overcoming neglect of kinetoplastid diseases Trypanosomiasis, African - transmission Trypanosoma cruzi - drug effects Chagas Disease - transmission Kinetoplastida - drug effects Euglenozoa Infections - drug therapy Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Euglenozoa Infections - transmission Leishmaniasis - drug therapy Antiprotozoal Agents - chemistry Chagas Disease - drug therapy Leishmaniasis - transmission Neglected Diseases - drug therapy Trypanosomiasis, African - drug therapy |
topic |
ddc 500 fid LING misc Trypanosomiasis, African - transmission misc Trypanosoma cruzi - drug effects misc Chagas Disease - transmission misc Kinetoplastida - drug effects misc Euglenozoa Infections - drug therapy misc Antiprotozoal Agents - adverse effects misc Antiprotozoal Agents - therapeutic use misc Euglenozoa Infections - transmission misc Leishmaniasis - drug therapy misc Antiprotozoal Agents - chemistry misc Chagas Disease - drug therapy misc Leishmaniasis - transmission misc Neglected Diseases - drug therapy misc Trypanosomiasis, African - drug therapy |
topic_unstemmed |
ddc 500 fid LING misc Trypanosomiasis, African - transmission misc Trypanosoma cruzi - drug effects misc Chagas Disease - transmission misc Kinetoplastida - drug effects misc Euglenozoa Infections - drug therapy misc Antiprotozoal Agents - adverse effects misc Antiprotozoal Agents - therapeutic use misc Euglenozoa Infections - transmission misc Leishmaniasis - drug therapy misc Antiprotozoal Agents - chemistry misc Chagas Disease - drug therapy misc Leishmaniasis - transmission misc Neglected Diseases - drug therapy misc Trypanosomiasis, African - drug therapy |
topic_browse |
ddc 500 fid LING misc Trypanosomiasis, African - transmission misc Trypanosoma cruzi - drug effects misc Chagas Disease - transmission misc Kinetoplastida - drug effects misc Euglenozoa Infections - drug therapy misc Antiprotozoal Agents - adverse effects misc Antiprotozoal Agents - therapeutic use misc Euglenozoa Infections - transmission misc Leishmaniasis - drug therapy misc Antiprotozoal Agents - chemistry misc Chagas Disease - drug therapy misc Leishmaniasis - transmission misc Neglected Diseases - drug therapy misc Trypanosomiasis, African - drug therapy |
format_facet |
Aufsätze Gedruckte Aufsätze |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
nc |
hierarchy_parent_title |
Science |
hierarchy_parent_id |
12931482X |
dewey-tens |
500 - Science |
hierarchy_top_title |
Science |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)12931482X (DE-600)128410-1 (DE-576)014533189 |
title |
Infectious diseases. Overcoming neglect of kinetoplastid diseases |
ctrlnum |
(DE-627)OLC1969525932 (DE-599)GBVOLC1969525932 (PRQ)pubmed_primary_260231240 (KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid |
title_full |
Infectious diseases. Overcoming neglect of kinetoplastid diseases |
author_sort |
Bilbe, Graeme |
journal |
Science |
journalStr |
Science |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
txt |
container_start_page |
974 |
author_browse |
Bilbe, Graeme |
container_volume |
348 |
class |
500 DNB LING fid |
format_se |
Aufsätze |
author-letter |
Bilbe, Graeme |
dewey-full |
500 |
title_sort |
infectious diseases. overcoming neglect of kinetoplastid diseases |
title_auth |
Infectious diseases. Overcoming neglect of kinetoplastid diseases |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-LING SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-FOR SSG-OLC-SPO SSG-OLC-IBL SSG-OLC-PHA SSG-OLC-DE-84 SSG-OPC-FOR GBV_ILN_11 GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_47 GBV_ILN_55 GBV_ILN_59 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_92 GBV_ILN_101 GBV_ILN_110 GBV_ILN_120 GBV_ILN_131 GBV_ILN_170 GBV_ILN_171 GBV_ILN_179 GBV_ILN_181 GBV_ILN_211 GBV_ILN_252 GBV_ILN_259 GBV_ILN_290 GBV_ILN_600 GBV_ILN_601 GBV_ILN_647 GBV_ILN_754 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2012 GBV_ILN_2015 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2116 GBV_ILN_2120 GBV_ILN_2121 GBV_ILN_2173 GBV_ILN_2185 GBV_ILN_2219 GBV_ILN_2221 GBV_ILN_2279 GBV_ILN_2286 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4036 GBV_ILN_4046 GBV_ILN_4125 GBV_ILN_4219 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4302 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4310 GBV_ILN_4314 GBV_ILN_4317 GBV_ILN_4318 GBV_ILN_4320 GBV_ILN_4324 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4700 |
container_issue |
6238 |
title_short |
Infectious diseases. Overcoming neglect of kinetoplastid diseases |
url |
http://www.ncbi.nlm.nih.gov/pubmed/26023124 |
remote_bool |
false |
ppnlink |
12931482X |
mediatype_str_mv |
n |
isOA_txt |
false |
hochschulschrift_bool |
false |
up_date |
2024-07-04T05:43:08.880Z |
_version_ |
1803625996098732032 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1969525932</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230714174343.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160211s2015 xx ||||| 00| ||eng c</controlfield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160211</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1969525932</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1969525932</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)pubmed_primary_260231240</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0063888920150000348623800974infectiousdiseasesovercomingneglectofkinetoplastid</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bilbe, Graeme</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Infectious diseases. Overcoming neglect of kinetoplastid diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trypanosomiasis, African - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trypanosoma cruzi - drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chagas Disease - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kinetoplastida - drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Euglenozoa Infections - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal Agents - adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal Agents - therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Euglenozoa Infections - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leishmaniasis - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal Agents - chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chagas Disease - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leishmaniasis - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neglected Diseases - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trypanosomiasis, African - drug therapy</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Science</subfield><subfield code="d">Washington, DC : AAAS, American Assoc. for the Advancement of Science, 1883</subfield><subfield code="g">348(2015), 6238, Seite 974</subfield><subfield code="w">(DE-627)12931482X</subfield><subfield code="w">(DE-600)128410-1</subfield><subfield code="w">(DE-576)014533189</subfield><subfield code="x">0036-8075</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:348</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:6238</subfield><subfield code="g">pages:974</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/26023124</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-MAT</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-FOR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-SPO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-IBL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_47</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_55</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_59</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_92</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_131</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_179</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_211</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_259</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_290</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_600</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_601</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_647</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_754</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2018</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2116</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2121</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2173</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2185</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2219</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2221</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2279</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2286</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4036</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4277</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4302</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4310</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4314</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4317</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4318</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4320</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4328</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">348</subfield><subfield code="j">2015</subfield><subfield code="e">6238</subfield><subfield code="h">974</subfield></datafield></record></collection>
|
score |
7.4007425 |